On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Kemotech SRL's own share of each project, not the project's full budget.
- Horizon 2020€189k · 2 projects
- FP7 (2007 to 2013)€156k · 1 project
Projects
3 EU-funded projects, newest first. Each links to the official record.
- MOGLYNETPartner
Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study
Horizon 2020 · 2015–2019 · Project on CORDIS ↗
- OCN4OSPartner
Organo-Catalytic Nanoparticles for Organic Synthesis
Horizon 2020 · 2015–2017 · Project on CORDIS ↗
€189ktheir share - ADAMANTPartner
ANTIBODY DERIVATIVES AS MOLECULAR AGENTS FOR NEOPLASTIC TARGETING
FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗
€156ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Eidgenoessische Technische Hochschule ZuerichSwitzerland · 1 shared project
- Universiteit AntwerpenBelgium · 1 shared project
- University College LondonUnited Kingdom · 1 shared project
- Academisch Ziekenhuis LeidenNetherlands · 1 shared project
- The University of NottinghamUnited Kingdom · 1 shared project
- Universitat de BarcelonaSpain · 1 shared project
- Universita Degli Studi di MilanoItaly · 1 shared project
- Universite de LiegeBelgium · 1 shared project
- The University Court of the University of AberdeenUnited Kingdom · 1 shared project
- Friedrich-Schiller-Universität JenaGermany · 1 shared project
- Royal College of Surgeons In IrelandIreland · 1 shared project
- Istituto di Ricerche Farmacologiche Mario NegriItaly · 1 shared project
- Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek en PatientenzorgNetherlands · 1 shared project
- Biomax Informatics AGGermany · 1 shared project
- Philochem AGSwitzerland · 1 shared project
- Linkcare Health Services SLSpain · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- arteriosclerosis
- biomolecules
- catalysis
- drug discovery
- medicinal chemistry
- nuclear medicine
- oncology
- pharmaceutical drugs
- polymer sciences
- radiation chemistry
- stroke
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
